BIOQUAL, Inc. provides contract research services primarily focused on animal models of human diseases including acquired immunodeficiency syndrome (AIDS), influenza, respiratory syncytial virus (RSV) infection, coronavirus infections (including COVID-19), flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other infectious diseases. It also performs in vitro contract research services. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.